T. Kawamori et al., Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor, CANCER LETT, 148(1), 2000, pp. 33-37
Nitric oxide synthase (NOS), an important bioregulator of a variety of biol
ogical processes, is overexpressed in colonic tumors of humans and rodents.
In this study, effects of L-NG-nitroarginine methyl ester (L-NAME), a NOS
inhibitor, on development of aberrant crypt foci (ACF) induced by azoxymeth
ane (AOM) in F344 male rats were investigated. Six-week-old male F344 rats
were fed diets containing 0 or 100 ppm L-NAME, and given s.c, injections of
AOM at 15 mg/kg body wt, once a week for 2 weeks. At 17 weeks of age, all
animals were sacrificed and their colons were evaluated for numbers of ACF.
Feeding of 100 ppm L-NAME inhibited the development of ACF in different si
zes by 24-39%, those containing four or more crypts being most markedly aff
ected, Assessment of silver-stained nucleolar organizer regions protein (Ag
NORs)/nucleus further revealed a 44% reduction by administration of L-NAME.
These results suggest that the NOS inhibitor, L-NAME, may be an effective
chemopreventive agent against colon carcinogenesis due to depression of cel
l proliferation. (C) 2000 Elsevier Science ireland Ltd. All rights reserved
.